Sivik Global Healthcare LLC Sells 8,000 Shares of HCA Healthcare, Inc. $HCA

Sivik Global Healthcare LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 32.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,000 shares of the company’s stock after selling 8,000 shares during the period. HCA Healthcare makes up approximately 2.1% of Sivik Global Healthcare LLC’s portfolio, making the stock its 3rd largest position. Sivik Global Healthcare LLC’s holdings in HCA Healthcare were worth $7,245,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HCA. Norges Bank purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at about $1,152,408,000. Pacer Advisors Inc. lifted its position in shares of HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares during the period. Viking Global Investors LP grew its holdings in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in HCA Healthcare in the second quarter valued at $109,337,000. Finally, Metropolis Capital Ltd grew its stake in HCA Healthcare by 76.6% in the 2nd quarter. Metropolis Capital Ltd now owns 603,029 shares of the company’s stock valued at $231,020,000 after acquiring an additional 261,592 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several research reports. Truist Financial increased their price target on shares of HCA Healthcare from $495.00 to $520.00 and gave the company a “buy” rating in a research report on Monday. Barclays raised their price target on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research report on Monday, December 15th. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, The Goldman Sachs Group boosted their price target on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $484.84.

HCA Healthcare Trading Up 1.2%

Shares of HCA Healthcare stock opened at $483.36 on Wednesday. The business’s fifty day moving average price is $479.33 and its 200 day moving average price is $425.71. The stock has a market capitalization of $110.30 billion, a P/E ratio of 18.68, a PEG ratio of 1.31 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the company posted $4.90 EPS. The company’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.